Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 30:2019:3872065.
doi: 10.1155/2019/3872065. eCollection 2019.

Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease

Xiao-Jun Chen  1   2 , Alfonso Eirin  1 , Garvan C Kane  3 , Sanjay Misra  4 , Stephen C Textor  1 , Amir Lerman  3 , Lilach O Lerman  1
Affiliations

Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease

Xiao-Jun Chen et al. Int J Hypertens. .

Abstract

Background: Percutaneous transluminal renal angioplasty (PTRA) improves blood pressure (BP) and renal function only in selected patients with atherosclerotic renovascular disease (ARVD). Hyperuricemia is associated with elevated risk for hypertension and chronic renal disease, but its role in renovascular hypertension is unclear. We hypothesized that hyperuricemia negatively impacts renal and BP outcomes among patients with ARVD undergoing PTRA.

Methods: This retrospective, observational cohort study included 94 patients with ARVD and preserved systolic cardiac function, who underwent PTRA at Mayo Clinic, Rochester, Minnesota. Renal, BP, and mortality outcomes were compared among patients according to their serum uric acid (SUA) levels. Multivariate analysis was used to determine significant predictors of renal, BP, and mortality outcomes after PTRA.

Results: Compared to patients with normal basal SUA levels (≤5.7 mg/dl), patients with very high SUA (≥8.7 mg/dl) had lower baseline estimated glomerular filtration rate (eGFR), more extensive use of antihypertensive and diuretic drugs, increased baseline systolic blood pressure (SBP), and elevated left ventricular mass index. After PTRA, multiple logistic regression analysis showed that, compared to normal SUA, very high SUA was associated with decreased odds ratio (OR) of change in eGFR (adjusted OR=0.90; 95% confidence interval [CI], 0.86-0.95), but not of change in SBP. In multivariate linear analysis SUA independently predicted delta urine protein/creatinine ratio (β: 26.0; 95% confidence interval, 13.9 to 38.1).

Conclusion: Severe hyperuricemia in patients with AVRD may have a negative impact on outcomes of renal revascularization.

PubMed Disclaimer

References

    1. Safian R. D., Textor S. C. Renal-artery stenosis. The New England Journal of Medicine. 2001;344(6):431–442. doi: 10.1056/NEJM200102083440607. - DOI - PubMed
    1. Anderson J. L., Halperin J. L., Albert N., et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1425–1443. doi: 10.1016/j.jacc.2013.01.004. - DOI - PubMed
    1. The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. The New England Journal of Medicine. 2009;361(20):1953–1962. doi: 10.1056/NEJMoa0905368. - DOI - PubMed
    1. Cooper C. J., Murphy T. P., Cutlip D. E., et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. The New England Journal of Medicine. 2014;370(1):13–22. doi: 10.1056/NEJMoa1310753. - DOI - PMC - PubMed
    1. Mohan I. V., Bourke V. The management of renal artery stenosis: An alternative interpretation of ASTRAL and CORAL. European Journal of Vascular and Endovascular Surgery. 2015;49(4):465–473. doi: 10.1016/j.ejvs.2014.12.026. - DOI - PubMed